Loading Video…
This browser does not support the Video element.
FDA approves muscular dystrophy drug
The decision comes just four months after the FDA denied the approval for the drug over concerns of kidney injury.
This browser does not support the Video element.
The decision comes just four months after the FDA denied the approval for the drug over concerns of kidney injury.